(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for ...

MedGenome: Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both ...

A U.S. stock rally fueled by Donald Trump’s election victory is stumbling, as investors contend with everything from renewed ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

Alnylam Pharmaceuticals ALNY presented new data from its early-stage study of nucresiran (formerly ALN-TTRsc04) for treating ...